Maxia Strategies GmbH

Swiss Biotech Association

Member

Maxia Strategies specializes in creating efficient product development strategies and providing supporting regulatory services. Our primary focus is helping small to medium-sized enterprises maximize the value of their products throughout their development lifecycle.

http://www.maxiastrategies.com
+41 61 511 4560
office@maxiastrategies.com
Dr. Karl E. Burgin

Location

Gellertstrasse 4, 4052 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2010
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Nice & Green SA

Based in Nyon, Nice & Green is an independent Swiss investment company offering alternative financings to S-Mid Cap listed companies. By combining indepth market expertise with cutting-edge proprietary tools, Nice & Green has become a preferred provider of alternative financing solutions in Europe.
Nyon

Member

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Member

Zenith Technologies

Zenith Technologies - a Cognizant Company transforms Life Sciences manufacturing with a focus on delivering speed to value. We provide scalable IT & OT end-to-end smart factory solutions, from conception through completion, across the manufacturing lifecycle.
4500 Solothurn

Member